Ann: ColoSTAT abstracts accepted at 2023 ASCO Annual Meeting, page-7

ASCO appears to be a very large, established and professional organisation whose main purpose is to provide education for doctors regarding new research and treatments in the oncology field. Attendance at their Annual Meeting would be quite important for medical folks who are motivated to be amongst the best.

IMHO, selection of the material presented would be thorough and carried out by well credentialed ASCO executives...

We already know that Colostat IS impressive on every level, and has reputable scientific proof backing it up...

So a bunch of executives who work at ASCO in the US already know all about it! In June, if not before, many hundreds or thousands more US medical professionals will know about it.

My opinion is, that amongst this US cohort of Colorectal cancer specialists, there is bound to be quite a few industry connections, lots of money, and strong potential for Colostat to be 'discovered'.

Rhythm only need one ripping US deal!